webleads-tracker

US Sunshine Act

New Jersey Finalizes “Gift” Ban of Physicians Working with the Pharmaceutical Industry

Transparence santé, Sunshine Act

In an unusual administrative move – without passing any new laws – on December 22, 2017, the Attorney General of New Jersey finalized new rules governing physician interactions with pharmaceutical companies. The rule is titled:   LIMITATIONS ON AND OBLIGATIONS ASSOCIATED WITH PRESCRIBER ACCEPTANCE OF COMPENSATION FROM PHARMACEUTICAL MANUFACTURERS. Starting January 15, 2018, all contracts and payments entered into by physicians directly with the pharmaceutical industry will be subject to a $10,000 total yearly cap for New Jersey physicians with all pharmaceutical companies. This includes payments from industry for consulting and speaking but exempts research and education related payments. In addition, …

Read More »

Blumenthal & Grassley Ask HHS to Prioritize Funding for Program to Enhance Transparency in Opioid Prescribing

[WASHINGTON, DC] – In a letter to Acting Secretary of the U.S. Department of Health and Human Services (HHS) Eric D. Hargan, U.S. Senators Richard Blumenthal (D-CT) and Chuck Grassley (R-IA), asked HHS to prioritize funding for the Center for Medicare and Medicaid Services’ Center for Program Integrity (CPI), a program that enhances transparency in transactions between medical providers and pharmaceutical companies. The CPI’s Open Payments database, created under the bipartisan Physician Payments Sunshine Act, mandates disclosure of billions of dollars in payments from manufacturers to prescribers and hospitals. This is of particular concern at a time when over-prescribing of …

Read More »

Pharma Billionaire Arrested On Charges of Bribing Doctors to Prescribe Opioid Painkillers

The same day President Donald Trump declared the opioid crisis a nationwide public health emergency, the federal government said it arrested a wealthy pharmaceutical company executive on charges of bribing doctors to needlessly prescribe his firm’s opioid painkiller. The Department of Justice arrested Insys Therapeutics founder John Kapoor, 74, in Phoenix, it said Thursday. Kapoor was charged with using bribes and fraud to prop up sales of a pain medication called Subsys, a fentanyl spray typically used to treat cancer patients suffering excruciating pain. Kapoor’s arrest comes nearly a year after former Insys CEO Michael Babich and five other onetime …

Read More »

California Gift Ban Bill to be Heard Tomorrow

Transparence santé, Sunshine Act

On Tuesday, June 27, 2017, California Senate Bill 790 will be heard in the Assembly Committee on Health, with limited testimony allowed per side. We have previously written about the bill, noting that the bill passed the California Senate back in May 2017. The bill, if passed as written, would prohibit a manufacturer of a prescribed product from offering or giving a gift to a health care provider. The bill would further prohibit a manufacturer of a prescribed product or an entity on behalf of a manufacturer of a prescribed product from providing a fee, payment, subsidy, or other economic …

Read More »

JAMA | Conflict of Interest: Why Does It Matter?

While endeavoring to protect the interests and well-being of their patients and maintain professional competence, physicians may develop secondary interests such as the competition for patients and trainees, extramural research funding, and high-profile publications. Financial and other rewards of medical practice can create conflicts of interest. This issue of JAMA features 23 Viewpoint articles on conflict of interest for physicians in settings such as academic medicine, biomedical research, medical education, guideline development, health care management, and medical publishing. Two Editorials discuss the pervasive opportunities for conflict of interest in health care and medical journalism. In This Issue of JAMA Highlights …

Read More »